Poet Technologies (POET 23.36%) is trying to turn its AI photonics story into real commercial momentum. The Lumilens order could validate the company's Optical Interposer platform, but investors still face a tense mix of tiny revenue, dilution risk, and execution pressure as the next 12 to 24 months become critical.
Stock prices used were the market prices of May 27, 2026. The video was published on June 5, 2026.





